| 000 | 02738cam a2200445Ii 4500 | ||
|---|---|---|---|
| 988 | _aSpringer_Medicine_2017 | ||
| 999 |
_c95025 _d95025 _x1 |
||
| 001 | 95025 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112643.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 161214s2017 sz ob 000 0 eng d | ||
| 020 | _a3319453955 | ||
| 020 |
_a3319453971 _q(electronic bk.) |
||
| 020 | _a9783319453958 | ||
| 020 |
_a9783319453972 _q(electronic bk.) |
||
| 020 | _z9783319453958 | ||
| 035 |
_a(OCoLC)965903422 _z(OCoLC)974651192 _z(OCoLC)981051277 _z(OCoLC)1005756832 _z(OCoLC)1011954023 |
||
| 040 |
_aN$T _cN$T _dN$T _dIDEBK _dGW5XE _dYDX _dAZU _dUAB _dCOO _dUPM _dOCLCF _dIOG _dVT2 _dESU _dJBG _dIAD _dICW _dICN _dOHI _dOTZ _dMERER _dOCLCQ _dU3W _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRC268.4 _b2017 EB |
|
| 245 | 0 | 0 |
_aEx vivo engineering of the tumor microenvironment _cAmir R. Aref, David Barbie, editors |
| 264 | 1 |
_aCham _bHumana Press _c2017 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 | _aCancer drug discovery and development | |
| 500 | _aSpringerLink | ||
| 504 | _aIncluye referencias bibliográficas | ||
| 505 | 0 | _a1. Introduction to Ex Vivo Cancer Models -- 2. Patient-derived Xenografts in Oncology -- 3.Organoid Culture: Applications in Development and Cancer -- 4. Microfluidics and future of cancer diagnostics -- 5. Advancing techniques and insights in circulating tumor cell (CTC) research -- 6. The Cancer Secretome -- 7. An overview of the tumor microenvironments and future of cancer therapy. | |
| 520 | 3 | _aThis volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time. | |
| 588 | 0 | _aOnline resource; title from PDF title page (EBSCO, viewed December 20, 2016). | |
| 650 | 7 |
_9273952 _aCáncer _2embne _xAspectos genéticos |
|
| 700 | 1 |
_aAref, Amir R., _eeditor literario |
|
| 700 | 1 |
_aBarbie, David, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-45397-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2018 _dz _e- _zSI |
||